Day: August 7, 2025

Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the six months of 2025. Challenges in Executing our Strategy Our strategy emphasizes developing governmental and social tenant concepts and centrally located, multi-functional properties with adaptable spaces designed to inspire, uplift, and enhance the lives of modern citizens and communities that holds potential for long-term value appreciation. We believe, that central locations represent a sound long-term investment, as their strategic positioning ensures sustained demand and strong potential for capital appreciation over time. Review of the KPIs:Occupancy target of 90% has been more difficult to achieve, as both leasing to new tenants and retaining existing ones have become increasingly challenging....

Management Board of Northern Horizon Capital AS has approved the unaudited financial results of Baltic Horizon Fund (the Fund) for the six months of 2025. Challenges in Executing our Strategy Our strategy emphasizes developing governmental and social tenant concepts and centrally located, multi-functional properties with adaptable spaces designed to inspire, uplift, and enhance the lives of modern citizens and communities that holds potential for long-term value appreciation. We believe, that central locations represent a sound long-term investment, as their strategic positioning ensures sustained demand and strong potential for capital appreciation over time. Review of the KPIs:Occupancy target of 90% has been more difficult to achieve, as both leasing to new tenants and retaining existing ones have become increasingly challenging....

Fly Play hf.: Financial Results Q2 2025Business plan on track by focusing on leisure routes, profit-driven network planning, and securing long-term ACMI agreements.Strong operations in Q2, with higher TRASK and lower adjusted CASK, though adverse FX movements and maintenance delay costs impacted results.Cash at the end of Q2 stood at USD 11.9 million, including restricted cash.PLAY has secured subscription commitments totalling USD 20 million (ISK 2.4 billion), expected to be finalised by mid-August, strengthening the company’s financial position going forward.Operating costs fell to USD 71.0 million in Q2 2025 from USD 74.1 million in Q2 2024, mainly due to reduced scheduled operations and drop in fuel costs from lower prices.PLAY carried 361k passengers in Q2 2025, down from 442k in 2024, as the company transitions...

August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 HighlightsEpcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epcoritamab plus R2 in patients with relapsed or refractory FL Rinatabart sesutecan (Rina-S®) continues to progress, demonstrating encouraging antitumor activity in endometrial cancer in data presented at the 2025 ASCO Annual Meeting Data from over 40 abstracts highlighting the depth, breadth and strength of Genmab’s comprehensive epcoritamab development program presented at multiple medical conferences Genmab revenue increased 19% compared to the first six months of 2024, to $1,640 million“In the first half of the year we continued to make progress towards our strategic priorities as we strive towards our goal of bringing our innovative therapies...